Clara Cell Protein (Club Cell Protein) is a New Diagnostic Molecular Candidate Biomarker in Nosocomial Pneumonia

Nosocomial pneumonia (NP) remains a relevant problem of resuscitation. Molecular biomarkers are significant promises for diagnosing NP. Objective: to estimate the informative value of the plasma levels of Clara cell protein (Club Cell Protein, CCP) as a diagnostic molecular candidate biomarker in NP. Subjects and methods. The investigation was conducted at the Research Institute of General Reanimatology (RIGR), Russian Academy of Medical Sciences (RAMS), in 2010—2013. It included 85 patients in accordance with the criteria of inclusion and exclusion and 30 donors. Acute respiratory distress syndrome and its stages were diagnosed using the criteria of RIGR, RAMS. Plasma Clara cell protein (CCP) levels were measured by the enzyme immunoassay Human Clara Cell Protein ELISA, RD191022200, BioVendor, USA. The findings were statistically analyzed using the package Statistica 7.0. ROC curve analysis was made to determine the sensitivity and
specificity of CCP. The difference at p<0.05 was considered significant. Results. On days 1, 3, 5, and 7 of the investigation, the plasma CCP levels in patients with NP were lower than in those without this disease. Within all these days, the plasma CCP concentrations in patients with and without NP were higher than in healthy donors. On days 1 and 3, the plasma content of CCP was much lower in patients in whom NP had been caused by Pseudomonas aeruginosa (in association with other pathogens) than in those with NP uncaused by Pseudomonas aeruginosa. Within the first 24 hours, the CCP level of 17.5 ng/ml had 86.5% sensitivity and 66.7% specificity in diagnosing Pseudomonas aeruginosainduced NP (area undercurve, 0.74; 95% confidence interval, 0.630—0.829; p=0.0001). The prognostic value of the positive and negative results of this test was 81.8 and 74.1%, respectively. Conclusion. The time course of changes in the plasma levels of Clara cell protein was studied in the patients with nosocomial pneumonia. Clara cell protein was shown to be of informative value in the diag nosis of Pseudomonas aeruginosainduced NP; on the day when nosocomial pneumonia was diagnosed, the plasma CCP level of 17.5 ng/ml had 86.5% sensitivity and 66.7% specificity in diagnosing Pseudomonas aeruginosainduced NP.

1. Karpun N.A., Moroz V.V., Klimova G.M., Akimkin V.G., Zhuravlev A.G., Kolesnik A.V. Profilaktika nozokomialnykh infektsii dykhatelnykh putei. Obshchaya Reanimatologiya. [Prevention of nosocomial espira tory infections. General Reanimatology]. 2007; 3 (3): 100–104. http://dx.doi.org/10.15360/1813977920073100. [In Russ.]

2. Golubev A.M., Moroz V.V., Sundukov D.V. Patogenez ostrogo respira tornogo distresssindroma. Obshchaya Reanimatologiya. [Pathogenesis of acute respiratory distress syndrome. General Reanimatology]. 2012; 8 (4): 13–21. http://dx.doi.org/10.15360/181397792012413. [In Russ.]

3. Kuzovlev A.N., Moroz V.V., Golubev A.M., Polovnikov S.G., Smelaya T.V. Diagnostika ostrogo respiratornogo distresssindroma pri nozokomial noi pnevmonii. Obshchaya Reanimatologiya. [Diagnosis of acute respi ratory distress syndrome in nosocomial pneumonia. General Reanimatology]. 2009; 5 (6): 5–12. http://dx.doi.org/10.15360/1813 9779200965. [In Russ.]

4. Chuchalin A.G. (red.). Nozokomialnaya pnevmoniya u vzroslykh. Natsionalnye rekomendatsii. [Adultonset pneumonia. National guide lines]. Moscow; 2009. [In Russ.]

5. Fagon J.Y. Diagnosis and treatment of ventilatorassociated pneumo nia: fiberoptic bronchoscopy with bronchoalveolar lavage is essential. Semin. Respir. Crit. Care Med. 2006; 27 (1): 34–44. http://dx.doi.org/10.1055/s2006933672. PMID: 16508880

6. Torres A., Rello J. Update in communityacquired and nosocomial pneumonia. Am. J. Respir. Crit. Care Med. 2010; 181 (8): 782–787. http://dx.doi.org/10.1164/rccm.2010010030UP. PMID: 20382801

7. Croce M.A. Diagnosis of acute respiratory distress syndrome and differentiation from ventilatorassociated pneumonia. Am. J. Surg. 2000; 179 (2 Suppl 1): 26–29. http://dx.doi.org/10.1016/S00029610(00)003196. PMID: 10874108

8. Fagon J.Y. Biologcal markers and diagnosis of ventilatorassociated pneumonia. Crit. Care. 2011; 15 (2): 130. http://dx.doi.org/10.1186/cc10050. PMID: 21418551

9. Vanspauwen M.J., Linssen C.F., Bruggeman C.A., Jacobs J.A., Drent M., Bergmans D.C., van Mook W.N. Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilatorassociated pneumonia? Crit. are. 2011; 15 (1): R14. http://dx.doi.org/10.1186/cc9418. PMID: 21223571

10. Johnston P., McAuley D.F., O’Kane C.M. Novel pulmonary biomarkers in the diagnosis of VAP. Thorax. 2010; 65 (3): 190–192. http://dx.doi.org/10. 1136/thx.2009.127308. PMID: 20335284

11. Luyt C.E., Combes A., Reynaud C., Hekimian G., Nieszkowska A., Tonnellier M., Aubry A., Trouillet J.L., Bernard M., Chastre J. Usefulness of procalcitonin for the diagnosis of ventilatorassociated pneumonia. Intensive Care Med. 2008; 34 (8): 1434–1440. http://dx.doi.org/ 10.1007/s001340081112x. PMID: 18421435

12. Tang H., Huang T., Jing J., Shen H., Cui W. Effect of procalcitoninguid ed treatment in patients with infections: a systematic review and meta analysis. Infection. 2009; 37 (6): 497–507. http://dx.doi.org/10.1007/s1501000990342. PMID: 19826761

13. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H. Creactive protein as a marker of ventilatorassociated pneumonia resolution: a pilot study. Eur. Respir. J. 2005; 25 (5): 804–812. http://dx.doi.org/10.1183/09031936.05.00071704. PMID: 15863636

14. Duflo F., Debon R., Monneret G., Bienvenu J., Chassard D., Allaouchiche B. Alveolar and serum procalcitonin: diagnostic and prognostic value in venti latorassociated pneumonia. Anesthesiology. 2002; 96 (1): 74–79. http://dx.doi.org/10.1097/0000054220020100000018. PMID: 11753005

15. Gibot S., Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells1 as a marker of microbial infection. Clin. Med. Res. 2004; 2 (3): 181–187. http://dx.doi.org/10.3121/cmr.2.3.181. PMID: 15931355

16. Determann R.M., Millo J.L., Gibot S., Korevaar J.C., Vroom M.B., van der Poll T., Garrard C.S., Schultz M.J. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during evelopment of ventilator associated pneumonia. Intensive Care Med. 2005; 31 (11): 1495–1500. http://dx.doi.org/10.1007/s0013400528187. PMID: 16195904

17. Oppert M., Reinicke A., Müller C., Barckow D., Frei U., Eckardt K. Elevations in procalcitonin but not Creactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation. 2002; 53 (2): 167–170. http://dx.doi.org/10.1016/S0300 9572(02)000084. PMID: 12009220

18. Moroz V.V. (red.). Ostryi respiratornyi distresssindrom: klassifikat siya, diagnostika, differentsirovannoe lechenie. Uchebnometodich eskoe posobie. [Acute respiratory distress syndrome: lassification, diagnosis, differentiated treatment. Guidance manual]. Moscow: NIIOR RAMN; 2013: 99. [In Russ.]

19. Kuzovlev A.N., Moroz V.V., Golubev A.M., Polovnikov S.G. Ingalyatsionnye antibiotiki v lechenii nozokomialnoi pnevmonii. Obshchaya Reanimatologiya. [Inhaled antibiotics in the treatment of nosocomial pneumonia. General Reanimatology]. 2013; 9 (6): 61–70. http://dx.doi.org/10.15360/181397792013661. [In Russ.]

20. Bernard A., Marchandise F.X., Depelchin S., Lauwerys R., Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur. Respir. J. 1992; 5 (10): 1231–1238. PMID: 1486970

21. Kropski J.A., Fremont R.D., Calfee C.S.,Ware L.B. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest. 2009; 135 (6): 1440–1447. http://dx.doi.org/10.1378/chest.082465. PMID: 19188556

22. Moroz V.V., Golubev A.M., Kuzovlev A.N., Pisarev V.M., Shabanov A.K., Golubev M.A. Surfaktantnyi protein D – biomarker ostrogo respira tornogo distresssindroma. Obshchaya Reanimatologiya. [Surfactant protein D is a biomarker of acute respiratory distress syndrome. General Reanimatology]. 2013; 9 (4): 11–17. http://dx.doi.org/10.15360/181397792013411. [In Russ.]

23. Moroz V.V., Golubev A.M., Kuzovlev A.N., Pisarev V.M., Polovnikov S.G., Shabanov A.K., Golubev M.A. Surfaktantnyi protein A (SPA) prognostichesky molekulyarnyi biomarker pri ostrom respiratornom dis tresssindrome. Obshchaya Reanimatologiya. [Surfactant protein А (SPA) is a prognostic molecular biomarker in acute respiratory dis tress syndrome. General Reanimatology]. 2013; 9 (3): 5–13. http://dx.doi.org/10.15360/18139779201335. [In Russ.]

24. Harrod K.S., Mounday A.D., Stripp B.R., Whitsett J.A. Clara cell secre tory protein decreases lung inflammation after acute virus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 1998; 275 (5 Pt 1): L924–L930. PMID: 9815110

25. Yao X.L., Levine S.J., Cowan M.J., Logun C., Shelhamer J.H. Tumor necrosis factoralpha stimulates human Clara cell secretory protein production by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 1998; 19 (4): 629–635. PMID: 9761760

26. Johnston C.J., Mango G.W., Finkelstein J.N., Stripp B.R. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am. J. Respir. Cell Mol. Biol. 1997; 17 (2): 147–155. http://dx.doi.org/10. 1165/ajrcmb.17.2.2676. PMID: 9271302

27. Lakind J.S., Holgate S.T., Ownby D.R., Mansur A.H., Helms P.J., Pyatt D., Hays S.M. A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers. 2007; 12 (5): 445–467. http://dx.doi.org/10.1080/13547500701359327. PMID: 17701745

28. Broeckaert F., Clippe A., Knoops B., Hermans C., Bernard A. Clara cell secre tory protein (CC16): features as a peripheral lung biomarker. Ann. N.Y.Acad. Sci. 2000; 923: 68–77. http://dx.doi.org/10.1111/j.17496632.2000.tb05520.x. PMID: 11193780

29. Determann R., Millo J., Waddy S., Lutter R., Garrard C., Schultz M. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilatorassociated pneumonia: a retrospective obser vational study. BMC Pulm. Med. 2009; 9: 49. http://dx.doi.org/ 10.1186/14712466949. PMID: 19958527

30. Cowan M., Huang X., Yao X.L., Shelhamer J.H. Tumor necrosis factor alpha stimulation of human Clara cell secretory protein production by human airway epithelial cells. Ann. N.Y. Acad. Sci. 2000; 923: 193–201. http://dx.doi.org/10.1111/j.17496632.2000.tb05530.x. PMID: 11193757

31. Harrod K., Mounday A., Whitsett J. Adenoviral E3–14.7K protein in LPSinduced lung inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2000; 278 (4): L631–L639. PMID: 10749739

32. Hayashida S., Harrod K., Whitsett J. Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2000; 279 (3): L452–L459. PMID: 10956619

33. Harrod K.S., Jaramillo R.J. Pseudomonas aeruginosa and tumor necrosis factoralpha attenuate Clara cell secretory protein promoter func tion. Am. J. Respir. Cell Mol. Biol. 2002; 26 (2): 216–223. PMID: 11804873